K-numberK252264
Device nameMEGELIN LED Light Therapy Mask (JML1, JML1+JML2); MEGELIN LED Light Therapy Mask (JML3, JML3+JML4); MEGELIN LED Light Therapy Mask (JML5, JML5+JML7); MEGELIN LED Light Therapy Mask (JML6, JML6+JML8); MEGELIN LED Light Therapy Mask (JML9, JML9+JML10)
ApplicantShenzhen Zhenxing Ruitong Technology Co., Ltd.
Product codeOHS
Device classClass II
Decision dateOct 17, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The MEGELIN LED Light Therapy Mask is an over-the-counter wearable device that uses red light (660±20nm) to treat full-face wrinkles and blue light (460±20nm) to treat mild to moderate inflammatory acne. It is available in multiple models (JML1–JML10) that serve as face or neck masks with varying energy density settings. The device is operated by placing it on the skin for 10–20 minutes per session and can be used by consumers aged 18 or older or by professional personnel.

Technological characteristics

The subject device uses LED light at wavelengths of 660nm (red) and 460nm (blue), with intensity settings ranging from 10–55 mW/cm² depending on model. It features a rechargeable lithium-ion battery with over 1000 hours of operational life and a 5-year product lifespan. The device is composed of silica gel, ABS, and polyurethane fiber materials and includes software/firmware microprocessor control for treatment timing and modes.

Test standards cited

IEC 60601-1, IEC 60601-1-2, IEC 60601-1-11, IEC 60601-2-83, IEC 62471, IEC 62133-2 (electrical safety and photobiological safety); ISO 10993-5, ISO 10993-10, ISO 10993-23 (biocompatibility including cytotoxicity, sensitization, and irritation).

Substantial equivalence argument

The MEGELIN mask is substantially equivalent to its predicates because it has identical intended use (OTC wrinkle reduction and acne treatment via red and blue LED light), the same regulatory classification (Class II, 21 CFR 878.4810), and similar technological characteristics. Minor differences in intensity ranges and wavelength tolerances fall within acceptable ranges of existing predicates and comply with relevant safety standards. All differences are considered non-material because they do not raise new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →